The skull marrow–meningeal immune circuit in Alzheimer’s disease: local hematopoietic remodeling and context-dependent neuroimmune functions
CNS-border immunology has advanced rapidly, but Alzheimer’s disease (AD) studies often leave the anatomical provenance of non-resident immune input unresolved. Skull marrow is a CNS-adjacent hematopoietic compartment with short-range access to the dura and access to cerebrospinal fluid-borne signals demonstrated in contextual studies. Two recent AD-related studies motivate a focused synthesis. Zhang et al. observed early skull-marrow Aβ enrichment in amyloid models; local Aβ challenge in wild-type mice induced IL-6-dependent B-cell and age-associated B-cell (ABC) responses. Regional labeling recovered skull-labeled B cells and ABCs from brain tissue, whereas a separate intraventricular ABC-delivery arm worsened amyloid-associated outcomes. These arms provide regional provenance and independent functional evidence, rather than a single natural causal chain. Xiong et al. linked osteoblast-lineage-initiated calvarial remodeling to myeloid redistribution, superficial perfusion and a limited early behavioral signal. Native calvarial myeloid provenance and mediation were not isolated. We propose Provenance × Lineage × Stage × Destination as a reporting and interpretive standard for evaluating these findings. This heuristic deconfounding framework identifies variables that currently prevent reliable comparison; it is not a validated causal model, and their independent contributions remain unmeasured. We distinguish cargo-responsive remodeling from niche-autonomous, skeletal-lineage-initiated remodeling without a demonstrated imported signal. The routes can coexist; mixed and indeterminate classifications prevent unsupported exclusivity. Four reporting dimensions are accompanied by separate checks of route, function and mediation. Human AD evidence remains largely structural and imaging-based; provenance-resolved cellular trafficking has not been demonstrated. The framework defines experimental priorities for determining whether skull-marrow outputs can eventually be modulated selectively.
Authors
- Ye Wang (ORCID: https://orcid.org/0000-0002-6729-7182)
- Jing Sun
- Qingwei Li
- Wei Gao
Institutions
- Heilongjiang University of Chinese Medicine (CN)
- First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN)
- Jiangsu College of Nursing (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fimmu.2026.1989042
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health